Interpace Biosciences, Inc. Stock
Stocks
IDXG
US46062X4025
Healthcare Facilities & Services
OTC Markets Traded|
Delayed
OTC Markets
22:25:06 29/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 5.720 USD | +15.56% |
|
+1.85% | -10.58% |
| Market Cap | 27.43M 24.57M 22.67M 20.51M 38.36M 2.61B 38.98M 270M 108M 1.37B 103M 101M 4.33B | P/E 2024 |
6.84x | P/E 2025 | 1.39x |
|---|---|---|---|---|---|
| Enterprise Value | 26.11M 23.39M 21.58M 19.52M 36.51M 2.49B 37.1M 257M 103M 1.3B 97.99M 95.9M 4.12B | EV / Sales 2024 |
0.35x | EV / Sales 2025 | 0.11x |
| Free-Float |
8.77% | Yield 2024 * |
-
| Yield 2025 | - |
OTC MarketsUSD
| Markets | Quality | ||
|---|---|---|---|
OTC Markets
| IDXG | Delayed | |
Börse Stuttgart
| PF4 | Delayed | |
|
Boerse Muenchen
| PF4 | Real-time |
| 1 day | +11.11% | ||
| 1 week | +1.85% | ||
| Current month | -13.93% | ||
| 1 month | -13.93% | ||
| 3 months | -29.11% | ||
| 6 months | -44.72% | ||
| Current year | -10.58% |
| 1 week | 4.95 |  | 6.5 |
| 1 month | 4.95 | | 6.5 |
| Current year | 4.95 | | 12 |
| 1 year | 4.03 | | 12 |
| 3 years | 2.22 | | 17.7 |
| 5 years | 2.22 | | 45.7 |
| 10 years | 2.22 | | 990 |
| Manager | Title | Age | Since |
|---|---|---|---|
Thomas Burnell
CEO | Chief Executive Officer | 64 | 01/12/2020 |
| Director of Finance/CFO | 34 | 21/04/2023 | |
Nicole Massoll
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Stephen Sullivan
CHM | Chairman | 79 | 21/06/2016 |
Joseph Keegan
BRD | Director/Board Member | 73 | 01/01/2016 |
Fortunato Rocca
BRD | Director/Board Member | 64 | 22/01/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 8/20/26 A | Free | Director | 69,252 | 0.2501% | ||
| 8/20/26 A | Exercice | Chief Financial Officer | 1,385,045 | 5.0015% | ||
| 8/20/26 A | Free | Director | 69,252 | 0.2501% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +15.56% | +1.85% | 0.00% | +30.33% | 27.43M | |
| +0.21% | -4.92% | +11.46% | +32.09% | 115B | |
| +3.01% | +2.18% | +1.94% | +113.80% | 100B | |
| +1.63% | +7.15% | +123.04% | +1,045.27% | 61.18B | |
| +1.49% | +1.62% | -6.81% | +89.51% | 29.09B | |
| +1.88% | +10.71% | +47.20% | +84.32% | 29.25B | |
| +2.67% | +3.53% | +44.11% | +94.63% | 27.02B | |
| -0.22% | -1.01% | +28.09% | +403.07% | 21.62B | |
| -0.72% | +2.93% | -17.96% | -1.64% | 20.81B | |
| +0.26% | -1.13% | -5.19% | +31.49% | 16.97B | |
| Average | +2.13% | +1.62% | +22.59% | +192.29% | 42.13B | |
| Weighted average by Cap. | +1.38% | +0.79% | +27.44% | +227.62% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 46.93M 42.03M 38.78M 35.09M 65.62M 4.47B 66.68M 463M 185M 2.34B 176M 172M 7.41B | 38.73M 34.69M 32M 28.96M 54.15M 3.69B 55.03M 382M 152M 1.93B 145M 142M 6.11B |
| Net income | 6.7M 6M 5.54M 5.01M 9.37M 638M 9.52M 66.07M 26.36M 334M 25.15M 24.62M 1.06B | 24.58M 22.01M 20.31M 18.38M 34.36M 2.34B 34.92M 242M 96.65M 1.22B 92.23M 90.26M 3.88B |
| Net Debt | 4.4M 3.94M 3.63M 3.29M 6.15M 419M 6.24M 43.33M 17.29M 219M 16.49M 16.14M 694M | -1.32M -1.18M -1.09M -989K -1.85M -126M -1.88M -13.03M -5.2M -65.89M -4.96M -4.86M -209M |
Employees
102
| Date | Price | Change | Volume |
|---|---|---|---|
| 29/10/26 | $5.720 | +15.56% | 5,107 |
| 28/10/26 | $4.950 | -10.00% | 1,880 |
| 26/10/26 | $5.500 | -15.38% | 3,314 |
| 23/10/26 | $6.500 | +20.37% | 2,753 |
| 22/10/26 | $5.400 | +6.93% | 124 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- IDXG Stock
Select your edition
All financial news and data tailored to specific country editions
